Alprazolam
Product Images NDC 0228-3083

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Alprazolam (NDC 0228-3083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

08adc1cc-figure-01 (Image 1)

Alprazolam Extended Release 1 mg tablet blister pack from Actavis Pharma, Inc. The packaging shows a grid of 14 peach-colored, oval-shaped tablets, each scored and labeled with dose markings. The blister material is clear plastic with silver foil backing.*

FDA Label Image

Image 10

Label for Alprazolam Extended-Release Tablets, USP 0.5 mg from Actavis Pharma, Inc., presenting a 60-tablet count. The label includes directions to dispense the accompanying Medication Guide, storage instructions at 25°C with allowed excursions, and barcode for serialization. Manufacturer listed as Teva Pharmaceuticals, Parsippany, NJ.*

FDA Label Image

Image 11

Label for Alprazolam Extended Release Tablets, USP 1 mg by Actavis Pharma, Inc. The label indicates a package containing 60 tablets. It includes dosing instructions, storage conditions, and a barcode. The label also references the medication guide at www.tevausa.com/medguides and lists Teva Pharmaceuticals, Parsippany, NJ as the manufacturer.*

FDA Label Image

Image 12

The image shows a label for Alprazolam Extended Release Tablets, USP, with a strength of 2 mg. The label indicates the product contains 60 tablets and is for Rx only. Manufactured for Teva Pharmaceuticals, Parsippany, NJ. The label includes storage instructions, medication guide dispensing info, and a barcode with NDC 0228-3087-06.*

FDA Label Image

Image 13

Label for Alprazolam Extended-Release Tablets, USP 3 mg by Actavis Pharma, Inc. The label indicates a package containing 60 tablets. It includes directions to dispense the accompanying medication guide, storage instructions at controlled room temperature, and a barcode with lot and expiration information. The label features the Teva logo and contact information for Teva Pharmaceuticals in Parsippany, NJ.*

FDA Label Image

08adc1cc-figure-02 (Image 2)

Packaging label for Alprazolam Extended Release tablets by Actavis Pharma, Inc. The label displays the product name prominently and includes an NDC code, a description of the extended-release formulation, strength information, and usage instructions. The design emphasizes clarity with a white background and black text, and includes regulatory and manufacturing details at the bottom.*

FDA Label Image

08adc1cc-figure-03 (Image 3)

The packaging label for Alprazolam Extended Release shows a white rectangular blister pack containing 10 round, white tablets arranged in two rows of five. The label includes the proprietary name "Alprazolam Extended Release" and the labeler, Actavis Pharma, Inc. No strength or additional information is visible in the image.*

FDA Label Image

08adc1cc-figure-04 (Image 4)

Alprazolam Extended Release tablet packaging label showing a white, round, biconvex tablet imprinted with 'ALP 2 mg'. The tablet is centrally positioned on the label with minimal text visible, and the label includes the proprietary name and strength. The labeler is Actavis Pharma, Inc.*

FDA Label Image

08adc1cc-figure-05 (Image 5)

Chemical structure of Alprazolam, the active ingredient in Alprazolam Extended Release by Actavis Pharma, Inc. The diagram shows a fused triazolobenzodiazepine ring system with a chlorine-substituted phenyl group and a methyl group attached to the nitrogen atoms.*

FDA Label Image

1 (Image 6)

Alprazolam Extended Release 1 mg tablets blister card packaging labeled by Actavis Pharma, Inc. The package shows a clear grid of 10 oval-shaped, beige tablets organized in two rows of five. The label includes the proprietary name and strength clearly printed.*

FDA Label Image

1 (Image 7)

Alprazolam Extended Release 3 mg tablets packaging label from Actavis Pharma, Inc. The label features text identifying the product name and strength, along with the manufacturer. The background includes a dark section with wave-like design elements.*

FDA Label Image

1 (Image 8)

The image shows the front of a brown prescription medicine bottle with a white child-resistant cap. The label identifies the product as Alprazolam Extended Release, but no strength or count is visible. The label also displays the Actavis Pharma, Inc. logo and basic regulatory text typical of prescription medication containers.*

FDA Label Image

1 (Image 9)

Alprazolam Extended Release tablet, labeled with strength 0.5 mg, manufactured by Actavis Pharma, Inc. The bottle packaging shows the product name prominently, dosage form as extended release tablet, and quantity as 30 tablets. The label includes usage and safety information in small print.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.